SubHero Banner
Text

September 2023

Core topics in this month’s edition include:

  • Comirnaty (Omicron XBB.1.5) and Spikevax (Omicron XBB.1.5) – vaccine approvals
  • COVID-19 Vaccines – Emergency Use Authorization
  • Jardiance (empagliflozin) – new indication
  • Tofidence (tocilizumab-bavi) – new biosimilar approval

Download PDF

Text